MRMD
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
138 days until earnings call
VRNOF
Price
$1.78
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
139 days until earnings call
Ad is loading...

MRMD vs VRNOF

Header iconMRMD vs VRNOF Comparison
Open Charts MRMD vs VRNOFBanner chart's image
MariMed
Price$0.17
Change-$0.00 (-0.00%)
Volume$1.14M
CapitalizationN/A
Verano Holdings
Price$1.78
Change-$0.00 (-0.00%)
Volume$590.11K
CapitalizationN/A
MRMD vs VRNOF Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRMD vs. VRNOF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRMD is a Sell and VRNOF is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (MRMD: $0.17 vs. VRNOF: $1.78)
Brand notoriety: MRMD and VRNOF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MRMD: 277% vs. VRNOF: 100%
Market capitalization -- MRMD: $137.81M vs. VRNOF: $1.01B
MRMD [@Pharmaceuticals: Other] is valued at $137.81M. VRNOF’s [@Pharmaceuticals: Other] market capitalization is $1.01B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRMD’s FA Score shows that 0 FA rating(s) are green whileVRNOF’s FA Score has 1 green FA rating(s).

  • MRMD’s FA Score: 0 green, 5 red.
  • VRNOF’s FA Score: 1 green, 4 red.
According to our system of comparison, VRNOF is a better buy in the long-term than MRMD.

Price Growth

MRMD (@Pharmaceuticals: Other) experienced а +14.83% price change this week, while VRNOF (@Pharmaceuticals: Other) price change was -12.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.99%. For the same industry, the average monthly price growth was -7.80%, and the average quarterly price growth was -7.77%.

Reported Earning Dates

MRMD is expected to report earnings on Apr 02, 2025.

VRNOF is expected to report earnings on Apr 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.99% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
VRNOF($1.01B) has a higher market cap than MRMD($138M). VRNOF has higher P/E ratio than MRMD: VRNOF (93.46) vs MRMD (13.33). MRMD YTD gains are higher at: -38.137 vs. VRNOF (-60.268). VRNOF has higher annual earnings (EBITDA): 36.4M vs. MRMD (22.7M). VRNOF has more cash in the bank: 95.1M vs. MRMD (21.7M). MRMD has less debt than VRNOF: MRMD (65M) vs VRNOF (502M). VRNOF has higher revenues than MRMD: VRNOF (904M) vs MRMD (137M).
MRMDVRNOFMRMD / VRNOF
Capitalization138M1.01B14%
EBITDA22.7M36.4M62%
Gain YTD-38.137-60.26863%
P/E Ratio13.3393.4614%
Revenue137M904M15%
Total Cash21.7M95.1M23%
Total Debt65M502M13%
FUNDAMENTALS RATINGS
MRMD: Fundamental Ratings
MRMD
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

MRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRMD has been loosely correlated with TSNDF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MRMD jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRMD
1D Price
Change %
MRMD100%
N/A
TSNDF - MRMD
44%
Loosely correlated
-2.00%
TCNNF - MRMD
41%
Loosely correlated
-6.28%
CRLBF - MRMD
40%
Loosely correlated
-2.78%
VRNOF - MRMD
37%
Loosely correlated
-7.29%
GLASF - MRMD
37%
Loosely correlated
-1.36%
More

VRNOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNOF has been closely correlated with GTBIF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if VRNOF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNOF
1D Price
Change %
VRNOF100%
-7.29%
GTBIF - VRNOF
79%
Closely correlated
-4.21%
CURLF - VRNOF
77%
Closely correlated
-1.79%
TCNNF - VRNOF
76%
Closely correlated
-6.28%
TSNDF - VRNOF
73%
Closely correlated
-2.00%
CRLBF - VRNOF
72%
Closely correlated
-2.78%
More